Life Biosciences

Boston, MA · Founded 2017 · Privately Held (backing)

Developer of drug therapies designed to improve the lives of people as they age. Life Biosciences is based in Boston, MA and was founded in 2017. Its last reported valuation was $500 million in Jan 2019. It has raised $255 million across 3 recorded rounds; the latest was a $31 million early-stage round in Nov 2025.

Last reported valuation
$500.0M
Oct 2026
Priced at
—
Total raised
$255.2M
Last round
Early Stage VC
Nov 2025

Who backs Life Biosciences?

16 investors
InvestorType
GaingelsVenture capital
Alpha Wave GlobalGrowth equity
The Venture CollectiveVenture capital
LeFrak—
Globalive CapitalFamily office
Reverb Capital—
Hybridge Capital Management—
Apple Core HoldingsVenture capital
Abundance PartnersVenture capital
Alzheimers Drug Discovery Foundation—
+ 6 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Life Biosciences investors

16 investors are on record for Life Biosciences, including Gaingels, Alpha Wave Global, The Venture Collective and LeFrak. By type, the record holds 4 venture capital firms, 1 family office and 1 growth equity firm. The early-stage round in Nov 2025 drew 8 investors.

Free account
More of Life Biosciences with a free account
  • ·The complete investor list: 16 names
  • ·Watch Life Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 16 firms already write checks for companies like Life Biosciences. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View